# The Efficacy and Optimal Dose of Sufentanil in Patient Controlled Analgesia After Moderate Surgery

> **NCT02503826** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital of Xi'an Jiaotong University** · enrollment: 60 (estimated)

## Conditions studied

- Analgesia, Patient-Controlled
- Gastrectomy
- Arthroplasty

## Interventions

- **DRUG:** Sufentanil
- **DRUG:** Sufentanil
- **DRUG:** Sufentanil
- **DRUG:** Midazolam
- **DRUG:** propofol
- **DRUG:** cisatracurium

## Key facts

- **NCT ID:** NCT02503826
- **Lead sponsor:** Second Affiliated Hospital of Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02503826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02503826, "The Efficacy and Optimal Dose of Sufentanil in Patient Controlled Analgesia After Moderate Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02503826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*